Invesco S&P 500 High Div Low Volatility ETF vs 22nd Century Group Inc — how do they compare? Invesco S&P 500 High Div Low Volatility ETF trades at $48.82 (market cap $3.14B), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: Invesco S&P 500 High Div Low Volatility ETF is far larger — about 5050.9× 22nd Century Group Inc's market cap, and Invesco S&P 500 High Div Low Volatility ETF is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Invesco S&P 500 High Div Low Volatility ETF for 125 Days and 22nd Century Group Inc for 32 Days on average.
| SPHD | XXII | |
|---|---|---|
Market Cap | $3.14B | $621.67K |
Volume | 1,461,349 | 45,625 |
52-Week High | $53.55 | $483.00 |
52-Week Low | $46.96 | $0.80 |
Typical Hold Time | 125 Days | 32 Days |
Sector | — | Consumer Staples |
Enterprise Value | — | -$3.69M |
Signals from Pluang's Aura AI — not financial advice
SPHD trades at $48.81, up 1.29% today, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The ETF focuses on high-dividend, low-volatility S&P 500 stocks, offering monthly income, but financial ratios are not disclosed in the provided data. Recent news highlights its role in retirement income strategies, though some analysts favor competitors like SCHD for total returns.
Outlook: SPHD appeals for steady dividend income amid market volatility, but risks include underperformance versus peers and sensitivity to interest rate changes. Investors should weigh the trade-off between yield and growth potential.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices LLC (the “index Provider”) compiles, maintains and calculates the underlying index, which is designed to measure the performance of 50 least volatile high yielding constituents of the S&P 500 ® Index in the past year.
Read more on SPHD →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →